Cabinet has agreed to progress stronger controls on 23 harmful substances, including the classification of three substances related to the potent opioid, fentanyl, Health Minister Simeon Brown says
An Auckland pharmacist and academic is concerned the planned roadside drug-testing regime may unfairly inconvenience some drivers appropriately taking prescription medicines.
An Auckland pharmacist and academic is concerned the planned roadside drug-testing regime may unfairly inconvenience some drivers appropriately taking prescription medicines
Pseudoephedrine became available for over-the-counter sale for the first time in 13 years on 20 May, after the ACT Party delivered on its election promise to undo the 2011 reclassification of the product as a prescription-only medicine. Jonathan Chilton-Towle looks at what pharmacies have experienced since then
Pseudoephedrine became available for over-the-counter sale for the first time in 13 years on 20 May, after the ACT Party delivered on its election promise to undo the 2011 reclassification of the product as a prescription-only medicine. Jonathan Chilton-Towle looks at what pharmacies have experienced since then
AS PSEUDOEPHEDRINE-RELATED crime is expected to rise with the return of products to pharmacy shelves, a New Zealand pharmaceutical company has created a pseudoephedrine product that is more difficult to use to manufacture methamphetamine.
As pseudoephedrine-related crime is expected to rise with the return of products to pharmacy shelves, a New Zealand pharmaceutical company has created a pseudoephedrine product that is more difficult to use to manufacture methamphetamine
Pharmacists say they are seeing an increase in drug seeking since pseudoephedrine-containing medicines returned to their shelves and are calling for a national register to record sales of the products
A Motueka pharmacy may have been the first in the country to get burgled for pseudoephedrine in 13 years, less than a week after the product became available again
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes